Skip to main content
Clinical Trials/NCT01844128
NCT01844128
Unknown
Not Applicable

The Effect of Weight Loss on Ovarian Reserve

Meir Medical Center1 site in 1 country100 target enrollmentMay 2013
ConditionsWeight Loss

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Weight Loss
Sponsor
Meir Medical Center
Enrollment
100
Locations
1
Primary Endpoint
Anti Mullerain Hormone (AMH)and AFC before and after weight loss
Last Updated
12 years ago

Overview

Brief Summary

Obesity affects on fertility. Obese women have lower pregnancy rate after infertility treatments.They need more doses of hormone during ovarian stimulation, more days for stimulation. During IVF treatment less oocytes are collected and the quality of embryo also harmed.

The first line treatment for those women with obesity and infertility is weight loss.

The investigators' hypothesis is that weight reduction improves ovarian reserve and fertility treatment outcome.

Detailed Description

The investigators have outpatient clinic for obesity and infertility. the patients undergoing program of 3 months with diet and physical activity. Blood sample will take at the beginning of the program and at the end. The blood sample will evaluate for: AMH, Adiponectin, Leptin, CRP, Colesterol, CRP, Smac in addition TVUS will perform to evaluate AFC.

Registry
clinicaltrials.gov
Start Date
May 2013
End Date
April 2014
Last Updated
12 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Amir Wiser

Senior physician IVF Unit

Meir Medical Center

Eligibility Criteria

Inclusion Criteria

  • undergoing weight loss program

Exclusion Criteria

  • dropp out before comletion the weighy loss target

Outcomes

Primary Outcomes

Anti Mullerain Hormone (AMH)and AFC before and after weight loss

Time Frame: 3 months

AMH and AFC will measure at the first visit and after 3 months of weight loss program

Study Sites (1)

Loading locations...

Similar Trials